NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Institute of Medicine (US); National Research Council (US); Pignone M, Russell L, Wagner J, editors. Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary. Washington (DC): National Academies Press (US); 2005.

Cover of Economic Models of Colorectal Cancer Screening in Average-Risk Adults

Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary.

Show details

Appendix JRecent Findings on Test Performance

, M.D., M.P.H.

Slide 1. Appendix J Recent Findings on Test Performance.

Slide 1

Appendix J Recent Findings on Test Performance. SLIDE 1 NOTES: I was asked to cover recent evidence on test performance for all the major colorectal cancer screening tests. I tried to take a meta-analytic approach to every test I examined, but was frustrated (more...)

Slide 2. Colorectal Cancer Screening Viable Tests.

Slide 2

Colorectal Cancer Screening Viable Tests. SLIDE 2 NOTES: Here is a list of what I consider tests that are viable for colorectal cancer screening. They begin with FOBTs and barium enema. These are to some extent viewed by both clinicians and the public (more...)

Slide 3. Fecal Occult Blood Tests.

Slide 3

Fecal Occult Blood Tests. SLIDE 3 NOTES: Fecal Occult Blood Tests (FOBTs) have been in use for several decades and provide some of the best data supporting the indication for CRC screening in order to prevent colorectal cancer (Ederer et al., 1997; Mandel (more...)

Slide 4. Test Performance FOBTs.

Slide 4

Test Performance FOBTs. SLIDE NOTES 4: FOBTs - There is a range of results reported for the GUAIAC-based stool studies, with sensitivity for detection of polyps ranging from 5-98% and sensitivity for detection of cancer of 18-92 percent. Specificity for (more...)

Slide 5. Test Performance Immunochemical FOBTs.

Slide 5

Test Performance Immunochemical FOBTs. SLIDE 5 NOTES: IFOBTS -- There is a broad range of results for Immunochemical FOBTs (IFOBTs) impacted by the number of studies used, the population screened, the ‘gold standard’ used and the lesion (more...)

Slide 6. FOBT vs. IFOBT.

Slide 6

FOBT vs. IFOBT. SLIDE 6 NOTES: A new article published by Ko and colleagues (Ko et al., 2003) looked at a population of veterans at varied risk for colorectal cancer, almost all male. The purpose of the study was to compare the overall performance of (more...)

Slide 7. Test Performance Barium Enema.

Slide 7

Test Performance Barium Enema. SLIDE 7 NOTES: Barium Enema --Though more widely used in the past, double-contrast barium enema (DCBE) has fallen out of favor with primary care providers, radiologists and gastroenterologists. The reason for this bias against (more...)

Slide 8. Test Performance Flexible Sigmoidoscopy.

Slide 8

Test Performance Flexible Sigmoidoscopy. SLIDE 8 NOTES: Flexible Sigmoidoscopy: This test has long been used for CRC screening, but has obvious limitations based on the length of insertion of the traditional Flexible Sigmoidoscopy (FlexSig) endoscope. (more...)

Slide 9. Test Performance Colonoscopy.

Slide 9

Test Performance Colonoscopy. SLIDE 9 NOTES: Colonoscopy -- Long considered the ‘gold standard’ for CRC screening, this test provides visualization of the entire colon and allows for removal of specimens for histopathologic assessment. (more...)

Slide 10. SLIDE 10 NOTES: STOOL DNA --Stool DNA is a provocative new technology.

Slide 10

SLIDE 10 NOTES: STOOL DNA --Stool DNA is a provocative new technology. Its development was based on a number of observations about the natural history of colorectal cancer. The progression of normal colonic mucosa through a series of mutational events (more...)

Slide 11. Test Performance Stool DNA.

Slide 11

Test Performance Stool DNA. SLIDE 11 NOTES: It has been determined from patients with proven CRC that a number of mutations can be detected in cells obtained from stool specimens that correspond to mutations in the neoplasm in those affected individuals. (more...)

Slide 12. Test Performance Virtual Colonoscopy.

Slide 12

Test Performance Virtual Colonoscopy. SLIDE 12 NOTES: Virtual colonoscopy is the latest technology to receive high visibility in the press. It is important to recognize, though, that this is still an evolving technology. As such, there has been a broad (more...)

Slide 13. Virtual Colonoscopy Studies All with n > 100.

Slide 13

Virtual Colonoscopy Studies All with n > 100. SLIDE 13 NOTES: Here is a list of the six studies with a sample size of 100 or greater. All have been reported in the recent past, before the conduct of this workshop. Note that the populations studied (more...)

Slide 14. V.C. Study Results Per Patient Analysis.

Slide 14

V.C. Study Results Per Patient Analysis. SLIDE 14 NOTES: Looking at the per-patient data gives the possibility of determining what will happen to patients who are subjected to screening by this modality. Across all six studies, the sensitivity for small (more...)

Slide 15. The Pickhardt Study -Methods.

Slide 15

The Pickhardt Study -Methods. SLIDE 15 NOTES: The Pickhardt Study -- In my opinion, The Pickhardt study (Pickhardt et al., 2003) is the one against which many others will be assessed in the future. This was a multi-center enrollment study. Average-risk (more...)

Slide 16. The Pickhardt Study –Diagnostic Methods.

Slide 16

The Pickhardt Study –Diagnostic Methods. SLIDE 16 NOTES: No notes.

Slide 17. The Pickhardt Study -Statistical Analysis.

Slide 17

The Pickhardt Study -Statistical Analysis. SLIDE 17 NOTES: The Pickhardt study employed segmental unblinding, which means that as the colonoscope passes through a segment, any indication from the VC results that a lesion may have been missed would lead (more...)

Slide 18. Pickhardt Results.

Slide 18

Pickhardt Results. SLIDE 18 NOTES: No notes.

Slide 19. Pickhardt Results – Test Performance.

Slide 19

Pickhardt Results – Test Performance. SLIDE 19 NOTES: To summarize comparative test performance, VC found 55 polyps not seen on OC, and 21 of those were tubular adenomas greater than 6 mm. The sensitivity for advanced neoplasia was 91.5 percent (more...)

Slide 20. Pickhardt Results.

Slide 20

Pickhardt Results. SLIDE 20 NOTES: The additional outcome measures described in this slide – extra-colonic findings, procedural time, and patient satisfaction – are secondary outcomes that may be important in evaluating the cost-effectiveness (more...)

Slide 21. Pickhardt Results Summary Statistics.

Slide 21

Pickhardt Results Summary Statistics. SLIDE 21 NOTES: Overall summary statistics for VC performance --with a cutoff range of 8 mm or greater, sensitivity and specificity of VC are greater than 90 percent. However, test positivity rates are high, which (more...)

Slide 22. Pickhardt Study: Questions/Issues.

Slide 22

Pickhardt Study: Questions/Issues. SLIDE 22 NOTES: No notes.

Slide 23. Test Performance Other Studies.

Slide 23

Test Performance Other Studies. SLIDE 23 NOTES: Here is a brief description of some provocative technologies ‘not (yet) ready for prime time:’ Flurodioxyglucose Positron Emission Tomography (FDG-PET) FDGs take up metabolically active cells. (more...)

Slide 24. Test Performance The Bottom-Line.

Slide 24

Test Performance The Bottom-Line. SLIDE 24 NOTES: This table shows the broad range of sensitivity and specificity for polyps and cancer across all of the technologies reviewed here.

Slide 25. Test Performance The Bottom-Line.

Slide 25

Test Performance The Bottom-Line. SLIDE 25 NOTES: No notes.

Slide 26. Summary Comments.

Slide 26

Summary Comments. SLIDE 26 NOTES: To summarize the entire literature, I would say that at present we have no clear gold standard for overall analysis. However, the segmentally unblinded colonoscopy using complementary studies is probably the best approach (more...)

Slide 27. Summary Comments.

Slide 27

Summary Comments. SLIDE 27 NOTES: No notes.


  • Adamsen S, Kronborg O. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol. 1984;19(4):531–4. [PubMed: 6463577]
  • Ahlquist DA, Shuber AP. Stool screening for colorectal cancer: evolution from occult blood to molecular markers. Clinica Chimica Acta. 2002;315(1-2):157–68. [PubMed: 11728417]
  • Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE, Thibodeau SN, Shuber AP. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterol. 2000;119(5):1219–27. [PubMed: 11054379]
  • Ahlquist DA. Molecular stool screening for colorectal cancer Using DNA markers may be beneficial, but large scale evaluation is needed. BMJ. 2000;321(7256):254–5. [PMC free article: PMC1118258] [PubMed: 10915110]
  • Beeker C, Kraft JM, Southwell BG, et al. Colorectal cancer screening in older men and women: qualitative research findings and implications for intervention. J Community Health. 2000;25(3):263–78. [PubMed: 10868818]
  • Bond JH. Colorectal Cancer Update. Prevention, Screening, Treatment and Surveillance for High-Risk Groups. Med Clin N Am. 2000;84:1163–82. [PubMed: 11026923]
  • Bouvier V, Herbert C, Lefevre H, Launoy G. Stage of extension and treatment for colorectal cancer after a negative test and among non-responders in mass screening with guaiac faecal occult blood test: a French experience. Eur J Cancer Prev. 2001;10(4):323–326. [PubMed: 11535874]
  • Boyle P, Zaridze DG, Smans M. Descriptive epidemiology of colorectal cancer. Int J Cancer. 1985;36:9–15. [PubMed: 2991145]
  • Brenes GA, Paskett ED. Predictors of stage of adoption for colorectal cancer screening. Prev Med. 2000;31(4):410–6. [PubMed: 11006067]
  • Brenner H, Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G. Long-lasting reduction of risk of colorectal cancer following screening endoscopy. Br J Cancer. 2001;85(7):972–6. [PMC free article: PMC2375093] [PubMed: 11592768]
  • Brevinge H, Lindholm E, Buntzen S, Kewenter J. Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55-56 years' old population. Int J Colorectal Dis. 1997;12(5):291–5. [PubMed: 9401844]
  • Brewster NT, Grieve DC, Saunders JH. Double-contrast barium enema and flexible sigmoidoscopy for routine colonic investigation. Br J Surg. 1994;81(3):445–7. [PubMed: 8173926]
  • Byrne MF. Primary Screening With Colonoscopy for Colorectal Cancer: A Targeted Algorithm. Am J Gastroenterol. 2003;98(12):2587–8. [PubMed: 14687801]
  • Chu KC, Tarone RE, Chow WH, Hankey BF, Ries LA. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst. 1994;86(13):997–1006. [see comment] [PubMed: 7980765]
  • Cirocco WC, Rusin LC. Factors that predict incomplete colonoscopy. Dis Colon Rect. 1995;38(9):964–8. [PubMed: 7656745]
  • Cooper GS, Yuan Z, Chak A, Rimm AA. Patterns of endoscopic follow-up after surgery for nonmetastatic colorectal cancer. Gastrointest Endosc. 2000;52(1):33–8. [PubMed: 10882959]
  • Dachman AH. Diagnostic performance of virtual colonoscopy. Abdom Imaging. 2002;27(3):260–7. [PubMed: 12173356]
  • de Zwart IM, Griffioen G, Shaw MP, Lamers CB, de Roos A. Barium enema and endoscopy for the detection of colorectal neoplasia: sensitivity, specificity, complications and its determinants. Clin Radiol. 2001;56(5):401–9. [PubMed: 11384140]
  • Drenth JP, Nagengast FM, Oyen WJ. Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Eur J Nucl Med. 2001;28(12):1766–9. [PubMed: 11734913]
  • Ederer F, Church TR, Mandel JS. Fecal occult blood screening in the Minnesota study: role of chance detection of lesions. J Natl Cancer Inst. 1997;89(19):1423–8. [see comment] [PubMed: 9326911]
  • Eisen GM, Kim CY, Fleischer DE, Kozarek RA, Carr-Locke DL, Li TC, Gostout CJ, Heller SJ, Montgomery EA, Al-Kawas FH, Lewis JH, Benjamin SB. High-resolution chromoendoscopy for classifying colonic polyps: a multicenter study. Gastrointest Endosc. 2002;55(6):687–94. [PubMed: 11979251]
  • Erban S, Zapka J, Puleo E, Vickers-Lahti M. Colorectal cancer screening in Massachusetts: measuring compliance with current guidelines. Eff Clin Pract. 2001;4(1):10–7. [PubMed: 11234181]
  • Favennec L, Kapel N, Meillet D, Chochillon C, Gobert JG. Detection of occult blood in stools: comparison of three gaiac tests and a latex agglutination test. Ann Biol Clin (Paris) 1992;50(5):311–3. [erratum appears in Ann Biol Clin (Paris) 1992. 50(8):618] [PubMed: 1485687]
  • Gann PH, Manson JE, Glynn RJ, et al. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst. 1993;85(15):1220–24. [PubMed: 8331682]
  • Giovanucci E, Rimm EB, Stampfer MJ, et al. Aspirin use and the risk of colorectal cancer and adenoma in male health professionals. Ann Intern Med. 1994;121:241–8. [PubMed: 8037405]
  • Glick S, Wagner JL, Johnson CD. Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer. AJR. Am J Roengenol. 1998;170(3):629–36. [PubMed: 9490943]
  • Gluecker T, Dorta G, Keller W, Jornod P, Meuli R, Schnyder P. Performance of multidetector computed tomography colonography compared with conventional colonoscopy. Gut. 2002;51(2):207–11. [PMC free article: PMC1773311] [PubMed: 12117881]
  • Gopalswamy N, Stelling HP, Markert RJ, Maimon HN, Wahlen SD, Haddy RI. A comparative study of eight fecal occult blood tests and HemoQuant in patients in whom colonoscopy is indicated. Arch Fam Med. 1994;3(12):1043–8. [PubMed: 7804488]
  • Greenberg PD, Bertario L, Gnauck R, Kronborg O, Hardcastle JD, Epstein MS, Sadowski D, Sudduth R, Zuckerman GR, Rockey DC. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol. 2000;95(5):1331–8. [PubMed: 10811348]
  • Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer Statistics, 2001. CA Cancer J Clin. 2001;(51):15–36. [PubMed: 11577478]
  • Hixson LJ, Fennerty MB, Sampliner RE, Garewal HS. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc. 1991;37(2):125–7. [PubMed: 2032595]
  • Hixson LJ, Fennerty MB, Sampliner RE, McGee D, Garewal H. Prospective study of the frequency and size distribution of polyps missed by colonoscopy. J Natl Cancer Inst. 1990;82(22):1769–72. [PubMed: 2231773]
  • Hope RL, Chu G, Hope AH, Newcombe RG, Gillespie PE, Williams SJ. Comparison of three faecal occult blood tests in the detection of colorectal neoplasia. Gut. 1996;39(5):722–5. [PMC free article: PMC1383398] [PubMed: 9014773]
  • Irvine EJ, O'Connor J, Frost RA, Shorvon P, Somers S, Stevenson GW, Hunt RH. Prospective comparison of double contrast barium enema plus flexible sigmoidoscopy v colonoscopy in rectal bleeding: barium enema v colonoscopy in rectal bleeding. Gut. 1988;29(9):1188–93. [comment] [PMC free article: PMC1434375] [PubMed: 3273756]
  • Itoh M, Takahashi K, Nishida H, Sakagami K, Okubo T. Estimation of the optimal cut off point in a new immunological faecal occult blood test in a corporate colorectal cancer screening programme. J Med Screen. 1996;3(2):66–71. [PubMed: 8849762]
  • Jeanson A, Jamart J, Maisin JM, Vanheuverzwyn R, Gohy P, Debongnie JC, Rentier B. Assessment of the new immunological test Hemoblot for detecting occult blood in faeces. Eur J Cancer Prev. 1994;3(5):407–12. [PubMed: 8000309]
  • Jensen J, Kewenter J, Asztely M, Lycke G, Wojciechowski J. Double contrast barium enema and flexible rectosigmoidoscopy: a reliable diagnostic combination for detection of colorectal neoplasm. Br J Surg. 1990;77(3):270–2. [PubMed: 2322788]
  • Johnson CD, Toledano AY, Herman BA, Dachman AH, McFarland EG, Barish MA, Brink JA, Ernst RD, Fletcher JG, Halvorsen RA Jr, Hara AK, Hopper KD, Koehler RE, Lu DS, Macari M, Maccarty RL, Miller FH, Morrin M, Paulson EK, Yee J, Zalis M., American College of Radiology Imaging Network. Computerized tomographic colonography: performance evaluation in a retrospective multicenter setting. Gastroenterol. 2003;125(3):688–95. [PubMed: 12949715]
  • Johnson CD, Carlson HC, Taylor WF, Weiland LP. Barium enemas of carcinoma of the colon: sensitivity of double- and single-contrast studies. AJR Am J Roentgenol. 1983;140(6):1143–9. [PubMed: 6602483]
  • Johnson CD, Harmsen WS, Wilson LA, Maccarty RL, Welch TJ, Ilstrup DM, Ahlquist DA. Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps. Gastroenterol. 2003;125(2):311–9. [comment] [PubMed: 12891530]
  • Kewenter J, Brevinge H, Engaras B, Haglind E. The yield of flexible sigmoidoscopy and double-contrast barium enema in the diagnosis of neoplasms in the large bowel in patients with a positive Hemoccult test. Endoscopy. 1995;27(2):159–63. [see comment] [PubMed: 7601048]
  • Kewenter J, Bjork S, Haglind E, Smith L, Svanvik J, Ahren C. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer. 1988;62(3):645–51. [PubMed: 3292038]
  • Khullar SK, DiSario JA. Colon cancer screening. Sigmoidoscopy or colonoscopy. Gastrointest Endosc Clin N Am. 1997;7(3):365–86. [PubMed: 9177140]
  • Kiesslich R, et al. Chromoendoscopy with indigocarmine improves the detection of adenomatous and nonadenomatous lesions in the colon. Endoscopy. 2001;33(12):1001–6. [see comment] [PubMed: 11740641]
  • Ko CW, Dominitz JA, Nguyen TD. Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests. Am J Med. 2003;115(2):111–4. [PubMed: 12893396]
  • Kronborg O. Colonic screening and surveillance. Best Practice & Research in Clinical Gastroenterology. 2001;15(2):301–16. [PubMed: 11355917]
  • Laghi A, Iannaccone R, Carbone I, Catalano C, Panebianco V, Di Giulio E, Schillaci A, Passariello R. Computed tomographic colonography (virtual colonoscopy): blinded prospective comparison with conventional colonoscopy for the detection of colorectal neoplasia. Endoscopy. 2002;34(6):441–6. [PubMed: 12048624]
  • Landis SH, Murray T, Bolden S, et al. Cancer Statistics. CA Cancer J Clin. 1999;49:8–13. [PubMed: 10200775]
  • Lee JH, et al. Detection of colorectal adenomas by routine chromoendoscopy with indigocarmine. Am J Gastroenterol. 2003;98(6):1284–8. [PubMed: 12818270]
  • Lee JH, Kim JW, Cho YK, Sohn CI, Jeon WK, Kim BI, Cho EY. Detection of colorectal adenomas by routine chromoendoscopy with indigocarmine. Am J Gastroenterol. 2003;98(6):1284–8. [PubMed: 12818270]
  • Leinicke JL, Dodds WJ, Hogan WJ, Stewart ET. A comparison of colonoscopy and roentgenography for detecting polypoid lesions of the colon. Gastrointest Radiol. 1977;2(2):125–8. [PubMed: 615812]
  • Lichtenstein GR, Park PD, Long WB, Ginsberg GG, Kochman ML. Use of a push enteroscope improves ability to perform total colonoscopy in previously unsuccessful attempts at colonoscopy in adult patients. Am J Gastroenterol. 1999;94(1):187–90. [PubMed: 9934753]
  • Lieberman D. Cost-effectiveness of screening colorectal cancer in the general population. Gastrointest Endosc. 2001;54(4):537–8. [PubMed: 11601425]
  • Lieberman DA, Weiss DG. Veterans Affairs Cooperative Study, One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med. 2001;345(8):555–60. [see comment][summary for patients in Gastrointest Endosc, 2002 May; 55(6): p. 760-1] [PubMed: 11529208]
  • Loose HW, Williams CB. Barium enema versus colonoscopy. Proc R Soc Med. 1974;67(10):1033–6. [PMC free article: PMC1646086] [PubMed: 4547846]
  • Luboldt W, Steiner P, Bauerfeind P, Peklonen P, Debatin JF. Detection of mass lesions with MR colonography: preliminary report. Radiology. 1998;207:59–65. [PubMed: 9530299]
  • Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328(19):1365–74. [PubMed: 8474513]
  • Markus JB, Somers S, O'Malley BP, Stevenson GW. Double-contrast barium enema studies: effect of multiple reading on perception error. Radiology. 1990;175(1):155–6. [PubMed: 2315474]
  • Miyoshi H, Oka M, Sugi K, Saitoh O, Katsu K, Uchida K. Accuracy of detection of colorectal neoplasia using an immunochemical occult blood test in symptomatic referred patients: comparison of retrospective and prospective studies. Intern Med. 2000;39(9):701–6. [PubMed: 10969900]
  • Morrin MM, et al. MR colonography using colonic distention with air as the contrast material: work in progress. AJR Am J Roentgenol. 2001;176(1):144–6. [PubMed: 11133554]
  • Nakama H, Zhang B, Zhang X. Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer. Eur J Cancer. 2001;37(3):398–401. [PubMed: 11239763]
  • Nakama H, Yamamoto M, Kamijo N, Li T, Wei N, Fattah AS, Zhang B. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia. Hepatogastroenterology. 1999;46(25):228–31. [PubMed: 10228797]
  • Nakama H, Kamijo N, Fujimori K, Fattah AS, Zhang B. Relationship between fecal sampling times and sensitivity and specificity of immunochemical fecal occult blood tests for colorectal cancer: a comparative study. Dis Colon Rectum. 1997;40(7):781–4. [PubMed: 9221852]
  • National Cancer Institute. http://www​
  • Nelson DB, McQuaid KR, Bond JH, Lieberman DA, Weiss DG, Johnston TK. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc. 2002;55(3):307–14. [PubMed: 11868001]
  • Newcomb PA, Storer BE, Morimoto LM, Templeton A, Potter JD. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst. 2003;95(8):622–5. [see comment] [PubMed: 12697855]
  • Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84(20):1572–5. [see comment] [PubMed: 1404450]
  • Niv Y, Sperber AD. Sensitivity, specificity, and predictive value of fecal occult blood testing (Hemoccult II) for colorectal neoplasia in symptomatic patients: a prospective study with total colonoscopy. Am J Gastroenterol. 1995;90(11):1974–7. [PubMed: 7485003]
  • Obrecht WF Jr, Wu WC, Gelfand DW, Ott DJ. The extent of successful colonoscopy: a second assessment using modern equipment. Gastrointest Radiol. 1984;9(2):161–2. [PubMed: 6745595]
  • Osgard E, Jackson JL, Strong J. A randomized trial comparing three methods of bowel preparation for flexible sigmoidoscopy. Am J Gastroenterol. 1998;93(7):1126–30. [PubMed: 9672343]
  • Ott DJ, Wu WC, Gelfand DW. Extent of colonic visualization with the fiberoptic sigmoidoscope. J Clin Gastroenterol. 1982;4(4):337–41. [PubMed: 7119410]
  • Painter J, Saunders DB, Bell GD, Williams CB, Pitt R, Bladen J. Depth of insertion at flexible sigmoidoscopy: implications for colorectal cancer screening and instrument design. Endoscopy. 1999;31(3):227–31. [see comment] [PubMed: 10344426]
  • Parikh A, Ramamoorthy R, Kim KH, Holland BK, Houghton J. Fecal occult blood testing in a noncompliant inner city minority population: increased compliance and adherence to screening procedures without loss of test sensitivity using stool obtained at the time of in- office rectal examination. Am J Gastroenterol. 2001;96(6):1908–13. [PubMed: 11419847]
  • Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1996. CA Cance J Clin. 1996;46(1):5–27. [PubMed: 8548526]
  • Pescatore P, Glucker T, Delarive J, Meuli R, Pantoflickova D, Duvoisin B, Schnyder P, Blum AL, Dorta G. Diagnostic accuracy and interobserver agreement of CT colonography (virtual colonoscopy) Gut. 2000;47(1):126–30. [PMC free article: PMC1727978] [PubMed: 10861274]
  • Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, Wong RK, Nugent PA, Mysliwiec PA, Schindler WR. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med. 2003;349(23):2191–2200. [see comment] [PubMed: 14657426]
  • Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(2):96–104. [comment][summary for patients in Ann Intern Med, 2002. 137(2): p. I38] [PubMed: 12118964]
  • Pineau BC, Paskett ED, Chen GJ, Espeland MA, Phillips K, Han JP, Mikulaninec C, Vining DJ. Virtual colonoscopy using oral contrast compared with colonoscopy for the detection of patients with colorectal polyps. Gastroenterol. 2003;125(2):304–10. [comment] [PubMed: 12891529]
  • Postic G, Lewin D, Bickerstaff C, Wallace MB. Colonoscopic miss rates determined by direct comparison of colonoscopy with colon resection specimens. Am J Gastroenterol. 2002;97(12):3182–5. [PubMed: 12492208]
  • Provenzale D. Cost-effectiveness of screening the average-risk population for colorectal cancer. Gastrointest Endosc Clin N Am. 2002;12(1):93–109. [PubMed: 11916165]
  • Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper DJ, Lehman GA, Mark DG. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterol. 1997;112(1):24–8. [see comment] [PubMed: 8978338]
  • Rex DK. Colonoscopic withdrawal technique is associated with adenoma miss rates. Gastrointest Endosc. 2000;51(1):33–6. [PubMed: 10625792]
  • Rex DK. Colonoscopy: a review of its yield for cancers and adenomas by indication. Am J Gastroenterol. 1995;90(3):353–65. [PubMed: 7872270]
  • Rex DK, Rahmani EY, Haseman JH, Lemmel GT, Kaster S, Buckley JS. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterol. 1997;112(1):17–23. [comment] [PubMed: 8978337]
  • Rex DK, Lehman GA, Lappas JC, Miller RE. Sensitivity of double-contrast barium study for left-colon polyps. Radiology. 1986;158(1):69–72. [PubMed: 3940401]
  • Rex DK. Rationale for colonoscopy screening and estimated effectiveness in clinical practice. Gastrointest Endosc Clin N Am. 2002;12(1):65–75. [PubMed: 11916162]
  • Rockey DC, Koch J, Cello JP, Sanders LL, McQuaid K. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests. N Engl J Med. 1998;339(3):153–9. [PubMed: 9664091]
  • Rozen P, Knaani J, Papo N. Evaluation and comparison of an immunochemical and a guaiac faecal occult blood screening test for colorectal neoplasia. Eur J Cancer Prev. 1995;4(6):475–81. [PubMed: 8580783]
  • Rozen P, Knaani J, Samuel Z. Comparative screening with a sensitive guaiac and specific immunochemical occult blood test in an endoscopic study. Cancer. 2000;89(1):46–52. [PubMed: 10896999]
  • Rozen P, Knaani J, Samuel Z. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia. Dig Dis Sci. 1997;42(10):2064–71. [PubMed: 9365136]
  • Rozen P. Prospects for the worldwide control of colorectal cancer through screening. Gastrointest Endosc. 2002;55(6):755–9. [PubMed: 11979269]
  • Saito Y, Slezak P, Rubio C. The diagnostic value of combining flexible sigmoidoscopy and double-contrast barium enema as a one-stage procedure. Gastrointest Radiol. 1989;14(4):357–9. [PubMed: 2806824]
  • Sakamoto K, Muratani M, Ogawa T, Nagamachi Y. Evaluation of a new test for colorectal neoplasms: a prospective study of asymptomatic population. Cancer Biother. 1993;8(1):49–55. [PubMed: 7812349]
  • Shehadeh I, Rebala S, Kumar R, Markert RJ, Barde C, Gopalswamy N. Retrospective analysis of missed advanced adenomas on surveillance colonoscopy. Am J Gastroenterol. 2002;97(5):1143–7. [PubMed: 12014718]
  • Shumaker DA, Zaman A, Katon RM. Use of a variable-stiffness colonoscope allows completion of colonoscopy after failure with the standard adult colonoscope. Endoscopy. 2002;34(9):711–4. [PubMed: 12195328]
  • Sieg A, Hertel A, John MR, Luthgens K, Schmidt-Gayk H. Screening for colorectal neoplasms with a new immunological human faecal haemoglobin and albumin test. Eur J Cancer Prev. 1998;7(4):279–85. [PubMed: 9806116]
  • Sieg A, Thoms C, Luthgens K, John MR, Schmidt-Gayk H. Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces. Int J Colorectal Dis. 1999;14(6):267–71. [PubMed: 10663892]
  • Silverman MA. Cancer screening in the elderly population. Hematol Oncol Clin North Am. 2000;14(1):89–112. [PubMed: 10680074]
  • Slattery ML, Edwards SL, Boucher KM, et al. Lifestyle and colon cancer: An assessment of factors associated with risk. Am J Epidemiol. 1999;150:869–77. [PubMed: 10522658]
  • Sonnenberg A. Cost-effectiveness in the prevention of colorectal cancer. Gastroenterol Clin North Am. 2002;31(4):1069–91. [PubMed: 12489279]
  • Spinzi G, Belloni G, Martegani A, Sangiovanni A, Del Favero C, Minoli G. Computed tomographic colonography and conventional colonoscopy for colon diseases: a prospective, blinded study. Am J Gastroenterol. 2001;96(2):394–400. [PubMed: 11232681]
  • Steine S, Stordahl A, Lunde OC, Loken K, Laerum E. Double-contrast barium enema versus colonoscopy in the diagnosis of neoplastic disorders: aspects of decision-making in general practice. Fam Pract. 1993;10(3):288–91. [PubMed: 8282153]
  • Stewart BT, Keck JO, Duncan AV, Santamaria NM, Allen P. Difficult or incomplete flexible sigmoidoscopy: implications for a screening programme. Aust N Z J Surg. 1999;69(1):19–21. [see comment] [PubMed: 9932914]
  • Sung JJ, Chan FK, Leung WK, Wu JC, Lau JY, Ching J, To KF, Lee YT, Luk YW, Kung NN, Kwok SP, Li MK, Chung SC. Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy. Gastroenterol. 2003;124(3):608–14. [PubMed: 12612899]
  • Tagore KS, Lawson MJ, Yucaitis JA, Gage R, Orr T, Shuber AP, Ross ME. Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia. Clinical Colorectal Cancer. 2003;3(1):47–53. [PubMed: 12777192]
  • Traverso G, Shuber A, Olsson L, Levin B, Johnson C, Hamilton SR, Boynton K, Kinzler KW, Vogelstein B. Detection of proximal colorectal cancers through analysis of faecal DNA. Lancet. 2002;359(9304):403–4. [PubMed: 11844514]
  • Trends in screening for colorectal cancer--United States, 1997 and 1999. MMWR Mortal Wkly Rep. 2001;50:162–66. [PubMed: 11393486]
  • Tsuda S, Veress B, Toth E, Fork FT. Flat and depressed colorectal tumours in a southern Swedish population: a prospective chromoendoscopic and histopathological study. Gut. 2002;51(4):550–5. [PMC free article: PMC1773398] [PubMed: 12235079]
  • Verne JE, Aubrey R, Love SB, Talbot IC, Northover JM. Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing. BMJ. 1998;317(7152):182–5. [PMC free article: PMC28612] [PubMed: 9665902]
  • Villa E, Dugani A, Rebecchi AM, Vignoli A, Grottola A, Buttafoco P, Losi L, Perini M, Trande P, Merighi A, Lerose R, Manenti F. Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool. Gastroenterol. 1996;110(5):1346–53. [comment] [PubMed: 8613038]
  • Walsh JM, Terdiman JP. Colorectal cancer screening: scientific review. JAMA. 2003;289(10):1288–96. [see comment] [PubMed: 12633191]
  • Walter SD, Frommer DJ, Cook RJ. The estimation of sensitivity and specificity in colorectal cancer screening methods. Cancer Detect Prev. 1991;15(6):465–9. [PubMed: 1782636]
  • Weaver P, Harrison B, Eskander G, et al. Colon cancer in blacks. A disease with a worsening prognosis. J Natl Med Assoc. 1991;83:133–38. [PMC free article: PMC2627026] [PubMed: 2005649]
  • Wherry DC, Thomas WM. The yield of flexible fiberoptic sigmoidoscopy in the detection of asymptomatic colorectal neoplasia. Surg Endosc. 1994;8(5):393–5. [see comment] [PubMed: 7772102]
  • Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut. 1982;23(10):835–42. [PMC free article: PMC1419830] [PubMed: 7117903]
  • Williams CB, Hunt RH, Loose H, Riddell RH, Sakai Y, Swarbrick ET. Colonoscopy in the management of colon polyps. Br J Surg. 1974;61(9):673–82. [PubMed: 4606357]
  • Winawer SJ, Shike M. Prevention and control of colorectal cancer. In: Greenwald P, Kramer BS, Weed DL, editors. Cancer Prevention and Control. Marcel Dekker; New York: 1995. pp. 537–539.
  • Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–81. [PubMed: 8247072]
  • Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterol. 1997;112:594–62. [PubMed: 9024315]
  • Wong BC, Wong WM, Chan JK, Lai KC, Hu WH, Chan CK, Lam SK, Carr-Locke DL. Virtual colonoscopy for the detection of colorectal polyps and cancers in a Chinese population. J Gastroenterol Hepatol. 2002;17(12):1323–7. [PubMed: 12423279]
  • Wong WM, Lam SK, Cheung KL, Tong TS, Rozen P, Young GP, Chu KW, Ho J, Law WL, Tung HM, Choi HK, Lee YM, Lai KC, Hu WH, Chan CK, Yuen MF, Wong BC. Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population. Cancer. 2003;97(10):2420–4. [PubMed: 12733140]
  • Yee J, Akerkar GA, Hung RK, Steinauer-Gebauer AM, Wall SD, McQuaid KR. Colorectal neoplasia: performance characteristics of CT colonography for detection in 300 patients. Radiology. 2001;219(3):685–92. [PubMed: 11376255]
  • Ziegler RG, DeVesa SS, Fraumeni J. Epidemiologic patterns of colorectal cancer. In: Devita VT, Hellman S, Rosenberg SA, editors. Important Advances in Oncology. Philadelphia: J. B. Lippincott; 1986.
Copyright © 2005, National Academy of Sciences.
Bookshelf ID: NBK83901


  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (5.4M)

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...